ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, despite MSC from CML patients do not express BCR–ABL [7], recent studies have reported an altered regulation of MSC in CML, showing that changes in BM microenvironmental function suppress normal hematopoietic stem cells (HSC) and provide a selective advantage to LSC[8].